H.R. 8066: Carlton H. Ingram Veterans’ Benefits Improvement Act
This bill, known as the Carlton H. Ingram Veterans’ Benefits Improvement Act, proposes changes to the way the Department of Veterans Affairs (VA) evaluates and rates disabilities for veterans. The key aspects of the bill include:
1. Revision of Disability Rating Methodology
The bill aims to amend Section 1155 of title 38 of the United States Code, which governs the disability rating system used by the VA. Specifically, it will adjust how the effects of medications or treatments are considered in the disability rating process.
2. Consideration of Medication and Treatment Effects
The new provisions will require that when determining disability ratings, the VA must be constructed to:
- Discount the beneficial effects of medication or treatment: This means that when assessing a veteran's disability, the VA should establish a baseline for the veteran’s condition without taking into account any positive impacts those medications or treatments may provide. Essentially, the focus will be on the underlying disability itself rather than how well a treatment is managing it.
3. Veterans' Compensation Rights
The bill clarifies that this approach will not prevent veterans from:
- Seeking compensation for additional disabilities that may arise due to medications or treatments prescribed for their service-related injuries or diseases.
- Claiming compensation for aggravation of preexisting injuries that were incurred during their military service.
Overall, the intent is to create a fairer and more transparent rating system that accurately reflects the disabilities of veterans without being influenced by any benefits received from treatments.
Relevant Companies
- None found
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
2 bill sponsors
Actions
2 actions
| Date | Action |
|---|---|
| Mar. 24, 2026 | Introduced in House |
| Mar. 24, 2026 | Referred to the House Committee on Veterans' Affairs. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.